AI assistant
Sending…
Pluri Inc. — Director's Dealing 2018
Dec 20, 2018
6990_dirs_2018-12-20_cf664e22-167a-4c4b-8d74-b9a7614a23a5.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: PLURISTEM THERAPEUTICS INC (PSTI)
CIK: 0001158780
Period of Report: 2018-12-19
Reporting Person: BEN-YORAM ISRAEL (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2018-12-19 | Common Stock | A | 49875 | — | Acquired | 265931 | Direct |
| 2018-12-19 | Common Stock | A | 49875 | — | Acquired | 315806 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 411250 | Indirect |
Footnotes
F1: The shares vest as follows: 25% shall vest on the 6 month anniversary of the date of grant and the remaining shares vest in 6 equal installments every 3 months thereafter.
F2: The shares vest as follows: 12.5% on the 27 month anniversary of the date of grant and the remaining shares vest in 7 equal installments every 3 months thereafter.
More from Pluri Inc.
Regulatory Filings
2026
Jun 2
Report Publication Announcement
2026
Jun 2
Report Publication Announcement
2026
Jun 1
Capital/Financing Update
2026
Jun 1
Capital/Financing Update
2026
Jun 1
Report Publication Announcement
2026
May 14
Interim / Quarterly Report
2026
May 14
Interim / Quarterly Report
2026
May 14
Annual Report
2026
Apr 23
Report Publication Announcement
2026
Apr 23